13F HOLDINGS REPORT
Alphabet Inc.
Quarter ended Q3 2023 · Filed August 4, 2023 · Accession 0001652044-23-000075
Total Value
$1.86B
Positions
56
Other Managers
6
Confidential Omitted
No
Holdings (56)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UiPath Inc | PATH | 13,662,543 | $226.4M | 12.16% |
| 2 | Verve Therapeutics Inc. | 92539P101 | 10,368,489 | $194.4M | 10.45% |
| 3 | Crowdstrike Hldgs Inc | CRWD | 1,283,683 | $188.5M | 10.13% |
| 4 | Prime Medicine, Inc. | PRME | 11,862,498 | $173.8M | 9.34% |
| 5 | Oscar Health Inc | OSCR | 21,344,748 | $172.0M | 9.24% |
| 6 | Dexcom Inc | DXCM | 1,212,806 | $155.9M | 8.37% |
| 7 | Gitlab Inc. | GTLB | 2,647,312 | $135.3M | 7.27% |
| 8 | Planet Labs Inc. | PL-WT | 31,942,641 | $102.9M | 5.53% |
| 9 | Snowflake Inc | SNOW | 535,604 | $94.3M | 5.06% |
| 10 | EQRx Inc. | 26886C107 | 47,252,687 | $87.9M | 4.72% |
| 11 | Freshworks Inc | FRSH | 2,094,204 | $36.8M | 1.98% |
| 12 | Lyft Inc | LYFT | 3,702,054 | $35.5M | 1.91% |
| 13 | Freshworks Inc | FRSH | 1,941,391 | $34.1M | 1.83% |
| 14 | Benson Hill Inc. | 082490103 | 15,352,271 | $20.0M | 1.07% |
| 15 | Relay Therapeutics Inc. | RLAY | 1,564,173 | $19.6M | 1.06% |
| 16 | Desktop Metal Inc. | 25058X105 | 11,048,730 | $19.6M | 1.05% |
| 17 | Lyell Immunopharma Inc. | LYEL | 5,865,125 | $18.7M | 1.00% |
| 18 | Sana Biotechnology Inc. | SANA | 2,812,500 | $16.8M | 0.90% |
| 19 | Oscar Health Inc | OSCR | 1,705,944 | $13.7M | 0.74% |
| 20 | Beam Therapeutics Inc. | BEAM | 321,604 | $10.3M | 0.55% |
| 21 | RAPT Therapeutics Inc. | 75382E109 | 540,270 | $10.1M | 0.54% |
| 22 | Monte Rosa Therapeutics Inc. | GLUE | 1,464,015 | $10.0M | 0.54% |
| 23 | Illumina Inc. | ILMN | 53,470 | $10.0M | 0.54% |
| 24 | UiPath Inc | PATH | 406,131 | $6.7M | 0.36% |
| 25 | Decibel Therapeutics Inc. | 24343R106 | 1,636,258 | $6.3M | 0.34% |
| 26 | Robinhood Mkts Inc | 770700102 | 612,214 | $6.1M | 0.33% |
| 27 | Invivyd Inc. | IVVD | 5,680,785 | $6.0M | 0.32% |
| 28 | Tenaya Therapeutics Inc. | TNYA | 915,705 | $5.4M | 0.29% |
| 29 | Vera Therapeutics Inc. | VERA | 301,580 | $4.8M | 0.26% |
| 30 | Oscar Health Inc. | OSCR | 481,988 | $3.9M | 0.21% |
| 31 | Foghorn Therapeutics Inc. | FHTX | 500,901 | $3.5M | 0.19% |
| 32 | Verve Therapeutics Inc | 92539P101 | 180,597 | $3.4M | 0.18% |
| 33 | Vaccitech PLC | BRNS | 1,513,644 | $3.1M | 0.17% |
| 34 | Tscan Therapeutics Inc. | TCRX | 1,077,080 | $2.7M | 0.14% |
| 35 | Magenta Therapeutics Inc. | 55910K108 | 3,339,138 | $2.5M | 0.14% |
| 36 | Kronos Bio Inc. | 50107A104 | 1,438,232 | $2.5M | 0.13% |
| 37 | Exact Sciences Corp | 30063P105 | 23,205 | $2.2M | 0.12% |
| 38 | Oscar Health Inc | OSCR | 255,092 | $2.1M | 0.11% |
| 39 | Oscar Health Inc | OSCR | 255,092 | $2.1M | 0.11% |
| 40 | Hyperfine Inc. | HYPR | 898,720 | $1.9M | 0.10% |
| 41 | Rani Therapeutics Hldgs Inc. | RANI | 448,492 | $1.8M | 0.10% |
| 42 | Autolus Therapeutics PLC | AUTL | 698,262 | $1.7M | 0.09% |
| 43 | Spero Therapeutics Inc. | SPRO | 889,979 | $1.3M | 0.07% |
| 44 | Alector Inc. | ALEC | 175,866 | $1.1M | 0.06% |
| 45 | EQRX Inc | 26886C107 | 422,789 | $786,388 | 0.04% |
| 46 | Science 37 Holdings Inc. | 808644108 | 3,207,260 | $673,524 | 0.04% |
| 47 | Oportun Finl Corp | 68376D104 | 94,788 | $565,884 | 0.03% |
| 48 | Taysha Gene Therapies Inc. | TSHA | 640,882 | $422,982 | 0.02% |
| 49 | Quince Therapeutics Inc | QNCX | 189,122 | $285,574 | 0.02% |
| 50 | Invitae Corp | 46185L103 | 235,606 | $266,235 | 0.01% |
| 51 | Evelo Biosciences Inc. | EVEX-WT | 53,024 | $172,328 | 0.01% |
| 52 | Mondee Holdings Inc. | 465712107 | 18,420 | $164,122 | 0.01% |
| 53 | Relay Therapeutics Inc | RLAY | 4,580 | $57,525 | 0.00% |
| 54 | Repligen Corp | RGEN | 383 | $54,179 | 0.00% |
| 55 | Fulcrum Therapeutics Inc | FULC | 14,262 | $47,065 | 0.00% |
| 56 | Cue Health Inc | 229790100 | 27,000 | $9,990 | 0.00% |